November 26th, 2025: Ozempic and Mounjaro Litigation Expands Following New Evidence of Heightened GI Risks A newly released study has increased scrutiny of GLP-1 receptor agonists such as Ozempic, Mounjaro, and Trulicity, linking these medications to substantially higher rates of gastrointestinal complications than older diabetes treatments
J., Flint, A., Gregersen, N
report any unusual symptoms to your PlexusDx-assigned clinician immediately
The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model
Theyre also rarely reported due to scarce occurrences
They get them from online companies who just want to take their money but get zero coaching or education as to how to eat or improve body composition